by Pharm Pals | Nov 14, 2020
PPALS-USP800 The ideal number of samples to obtain, the size of those samples and the acceptable limits for surface contamination are all as follows:
by Pharm Pals | Nov 14, 2020
PPALS-USP800 The environment should be evaluated on a routine basis using wipe sampling for hazardous drug residues. The recommended time frame is as follows:
by Pharm Pals | Nov 14, 2020
PPALS-USP800 If a facility only occasionally compounds non-sterile hazardous drugs, a C-PEC designated for sterile compounding can be used but it must be as follows:
by Pharm Pals | Nov 14, 2020
PPALS-USP800 To ensure safety, especially when handling hazardous drugs, sterile and non-sterile compounding must be performed in the following settings:
by Pharm Pals | Nov 14, 2020
PPALS-USP800 Water sources and drains must be one meter away from the C-PEC so as not to, as follows:
